Abstract
The Chronic Respiratory Questionnaire (CRQ) and the St George's Respiratory Questionnaire (SGRQ) are the two most widely used quality of life questionnaires in chronic obstructive pulmonary disease (COPD). A study was undertaken to compare directly the self-administered version of the CRQ and the SGRQ with respect to feasibility, internal consistency, validity, and sensitivity to changes resulting from bronchodilator therapy. One hundred and forty four patients with moderate or severe COPD were randomly assigned to receive three months of treatment with either salmeterol, salmeterol + ipratropium bromide, or placebo. Quality of life was measured at baseline and after 12 weeks of treatment. The proportions of missing values per patient were low for both questionnaires (0.54% for the CRQ and 2% for the SGRQ). The internal consistency was good for both questionnaires (Cronbach's alpha coefficients >/= 0.84 for the CRQ and >/= 0.76 for the SGRQ). Factor analysis confirmed the original domain structure of the CRQ but not of the SGRQ. Correlations with forced expiratory volume in one second (FEV(1)) % predicted and peak expiratory flow rate (PEFR) were low for both questionnaires but better for the SGRQ than for the CRQ. The ability to discriminate between subjects with different levels of FEV(1) was somewhat better for the SGRQ. The correlations with symptom scores were comparable for both questionnaires. Cross sectionally, the scores of the two questionnaires were moderately to highly correlated (coefficients ranged from 0.35 to 0.72). Longitudinally, these correlations were lower (coefficients ranged from 0.17 to 0.54) but were still significant. The CRQ total and emotions score and the SGRQ symptoms score were the most responsive to change. The SGRQ symptoms domain was the only domain where the improvement in patients receiving combination treatment crossed the threshold for clinical relevance. Since this analysis of reliability, validity, and responsiveness to change did not clearly favour one instrument above the other, the choice between the CRQ and the SGRQ can be based on other considerations such as the required sample size or the availability of reference values.
MeSH Terms
Adult
Aged
Albuterol/analogs & derivatives,therapeutic use
Bronchodilator Agents/therapeutic use
Double-Blind Method
Feasibility Studies
Female
Humans
Ipratropium/therapeutic use
Lung Diseases, Obstructive/drug therapy
Male
Middle Aged
Quality of Life
Reproducibility of Results
Salmeterol Xinafoate
Sensitivity and Specificity
Surveys and Questionnaires/standards
Chemicals
Bronchodilator Agents
Salmeterol Xinafoate
Ipratropium
Albuterol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rutten-van Mölken M
Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands.
Roos B
Van Noord J A
References (25)
25 references, click to expand
-
Quality of life changes in COPD patients treated with salmeterol.
Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9
PMID: 9105068
-
Clinical impact versus factor analysis for quality of life questionnaire construction.
J Clin Epidemiol. 1997 Mar;50(3):233-8
PMID: 9120521
-
Long-term outcome of pulmonary rehabilitation in patients with COPD.
Chest. 1997 Aug;112(2):363-9
PMID: 9266870
-
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.
Thorax. 1997 Oct;52(10):879-87
PMID: 9404375
-
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90
PMID: 9517591
-
Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis.
Eur Respir J. 1998 Dec;12(6):1284-9
PMID: 9877478
-
Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy.
Eur Respir J. 1997 Jul;10(7):1572-5
PMID: 9230249
-
A measure of quality of life for clinical trials in chronic lung disease.
Thorax. 1987 Oct;42(10):773-8
PMID: 3321537
-
Should study subjects see their previous responses: data from a randomized control trial.
J Clin Epidemiol. 1989;42(9):913-20
PMID: 2778469
-
Measurement of health status. Ascertaining the minimal clinically important difference.
Control Clin Trials. 1989 Dec;10(4):407-15
PMID: 2691207
-
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
Respir Med. 1989 Jul;83(4):293-7
PMID: 2692093
-
Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries.
Eur Respir J. 1991 Feb;4(2):167-71
PMID: 2044732
-
The St George's Respiratory Questionnaire.
Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7
PMID: 1759018
-
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
PMID: 1595997
-
Reliability and validity of the chronic respiratory questionnaire (CRQ).
Thorax. 1994 May;49(5):465-7
PMID: 8016767
-
Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
Thorax. 1994 May;49(5):479-84
PMID: 8016770
-
Randomised controlled trial of respiratory rehabilitation.
Lancet. 1994 Nov 19;344(8934):1394-7
PMID: 7968075
-
[The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease].
Arch Bronconeumol. 1995 May;31(5):202-10
PMID: 7788081
-
Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.
Thorax. 1995 Aug;50(8):824-8
PMID: 7570431
-
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.
Eur Respir J. 1995 Aug;8(8):1398-420
PMID: 7489808
-
[Validation of the St George's questionnaire for measuring the quality of life in patients with chronic obstructive pulmonary disease].
Rev Mal Respir. 1996;13(1):43-6
PMID: 8650415
-
Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
Eur Respir J. 1996 Jun;9(6):1160-6
PMID: 8804932
-
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet. 1996 Oct 26;348(9035):1115-9
PMID: 8888163
-
Assessing the minimal important difference in symptoms: a comparison of two techniques.
J Clin Epidemiol. 1996 Nov;49(11):1215-9
PMID: 8892486
-
The minimal important difference: who's to say what is important?
J Clin Epidemiol. 1996 Nov;49(11):1221-2
PMID: 8892487